SanDisk Corp. (NASDAQ:SNDK) told investors this week that it expects non-GAAP gross margins to sustain at approximately 80%, with operating margins near 75%, from fiscal 2028 through fiscal 2030, under a new financial model built around long-term supply agreements. The company, which focuses on …
T Rowe Price, the $1.9 trillion asset management firm, reported net outflows of $6.5 billion for the quarter ending June 30, marking its 21st consecutive quarter of redemptions, though the figure represented a moderation from the two prior quarters. Chief executive Rob Sharps said …
Padmanabh P. Bhatt, Senior Vice President of IP and Chief Scientific Officer of Supernus Pharmaceuticals, Inc., filed a Form 4 on August 14, 2026, disclosing transactions in common stock on August 12, 2026, related to the vesting of Performance Share Units.
Jonathan Rubin, SVP and Chief Medical Officer of Supernus Pharmaceuticals, Inc., filed a Form 4 on August 14, 2026, disclosing transactions in common stock dated August 12, 2026, related to the vesting of Performance Share Units.
Jack A. Khattar, President and CEO of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), filed a Form 4 on August 14, 2026, reporting the vesting of Performance Share Units and a related tax withholding transaction dated August 12, 2026.
Yann Mazabraud, EVP and Head of International at Rhythm Pharmaceuticals, Inc., filed a Form 4 on August 14, 2026, disclosing a stock option exercise and the sale of common shares on August 12, 2026, all executed under a pre-established Rule 10b5-1 trading plan.
Jennifer Kayden Lee, Executive Vice President and Head of North America at Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), filed a Form 4 on August 14, 2026, reporting stock option exercises and a same-day sale of common stock executed on August 13, 2026.
CoreWeave, Inc. Chief Operating Officer Sachin Jain filed a Form 4 on August 14, 2026, disclosing a sale of Class A Common Stock on August 12, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
Dara S. Redler, Chief Legal and Administrative Officer of H&R Block Inc, filed a Form 4 on August 14, 2026, reporting the acquisition of 17,271 shares of common stock on August 12, 2026, through the vesting of performance share units.
Corteva, Inc. filed a current report on August 14, 2026, disclosing that its subsidiary Vylor, Inc. submitted the first amendment to a Form 10 registration statement with the U.S. Securities and Exchange Commission in connection with Corteva's previously announced plan to separate its seed …